YUMAB is a company that specializes in contract research, technologies, and R&D services for the development of antibodies. It builds a platform with human antibody libraries that provides in vitro selection technologies including on-cells-selection for difficult targets. In addition, the platform offers a comprehensive portfolio of antibody engineering and humanization technologies.